The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Fourth Oaktree Letter

6 Jun 2018 16:49

RNS Number : 5575Q
Ranger Direct Lending Fund PLC
06 June 2018
 

Ranger Direct Lending Fund plc

("Ranger" or the "Company")

 

Response to Fourth Oaktree Letter

 

The independent directors of Ranger ("Independent Directors") note the announcement from Oaktree Capital Management, L.P. ("Oaktree") today.

 

The Independent Directors welcome that Oaktree now acknowledges that a winding up of Ranger is not the only option for the future of the Company and responds to Oaktree's other comments below.

 

Review Process

The investment management review process ("the process") has been run by the Independent Directors who note that Oaktree is the only major shareholder in Ranger not to take up the opportunity of a presentation from Ares Management LLC ("Ares") on the detail of its proposed future investment strategy. The Independent Directors believe that the new investment policy will enhance the capital stability of the Company going forward to the benefit of both ordinary shareholders and Zero Dividend Preference ("ZDP") shareholders.

 

During the process, the Independent Directors have looked to balance the interests of all stakeholders. The process involved two rounds of written submissions from potential investment managers, including details dealing with the legitimate interests of the ZDP shareholders. Oaktree was invited to participate in the process but declined. It is the Independent Director's view that if Oaktree had fully engaged in the process, it would understand how the Independent Board conducted a robust, fair and balanced process.

 

The Independent Directors and their advisers continue to be in positive discussions with shareholders on the Ares proposal and related matters. Ares is also in dialogue with shareholders on the detail of the proposed new investment policy. The Independent Directors believe that the majority of shareholders want this level of engagement to be able to reach an informed view on the future of the Company.

 

Future of the Company

The Independent Directors welcome Oaktree's statement today that its nominees for Board positions "are committed to exploring all strategic alternatives for the Company in order to maximise value", and that they are willing to engage "with potential new managers including Ares". However, the Independent Directors have to reflect that this public pronouncement is not corroborated by Oaktree's recent conduct. In its open letter to shareholders of 4 May 2018, Oaktree concluded that a winding up of Ranger was the only way forward for the Company. Oaktree has since engaged in a disruptive campaign seeking to force through a winding up of the Company, irrespective of the interests of other longer-term shareholders.

 

Future Board Composition

The Independent Directors of Ranger have engaged actively with shareholders during the process on the future composition of the Board. The EGM circular will include a commitment to appoint additional non-executive directors with relevant experience, after further consultation with shareholders. If appointed, Ares will not have a Board representative, and non-independent non-executive director, Mr. K. Scott Canon, the CEO of Ranger Capital Group, has confirmed he will resign as a director of the Company following the EGM. The Independent Directors welcome the recommendation by Institutional Shareholder Services (ISS), that clients vote against resolutions 8,9.10,11 and 12 at the AGM to be held on 19 June 2018.

 

Recommendation

The Board will publish all relevant information ahead of shareholders making a decision on the AGM resolutions relating to the appointment and removal of directors. As stated in the notice of the meeting, the Board recommends that shareholders vote against resolutions 8, 9, 10, 11 and 12 at the AGM to be held on 19 June 2018.

 

An EGM circular will be sent to shareholders following regulatory approval.

 

Contacts:

 

Ranger Direct Lending Fund plc

Christopher Waldron (Chairman)

 

Via Kinmont

Kinmont

Gavin Kelly

 

Tel: +44 (0)20 7087 9134

 

Liberum

Joshua Hughes

 

Tel: +44 (0)20 3100 2000

Redleaf (for media enquiries)

Robin Tozer

Tel: + 44 (0) 20 3757 6867

ranger@redleafpr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBUGDLLSGBGIL
Date   Source Headline
3rd Nov 20173:45 pmRNSNet Asset Value(s)
3rd Nov 20173:45 pmRNSMonthly Update
1st Nov 20177:00 amRNSStrategic Partner Discussions
23rd Oct 20172:14 pmRNSPortfolio Update
9th Oct 20174:35 pmRNSMonthly Update
9th Oct 20174:34 pmRNSNet Asset Value(s)
26th Sep 20177:00 amRNSHalf-year Report
15th Sep 20174:35 pmRNSPrice Monitoring Extension
13th Sep 20174:34 pmRNSMonthly Update
13th Sep 20174:32 pmRNSNet Asset Value(s)
14th Aug 20174:05 pmRNSHolding(s) in Company
11th Aug 20173:17 pmRNSDividend Declaration
9th Aug 20172:43 pmRNSHolding(s) in Company
8th Aug 20174:47 pmRNSHolding(s) in Company
7th Aug 20172:40 pmRNSHolding(s) in Company
4th Aug 20178:45 amRNSMonthly Update
4th Aug 20178:45 amRNSNet Asset Value(s)
31st Jul 20174:33 pmRNSHolding(s) in Company
26th Jul 20172:56 pmRNSDirector/PDMR Shareholding
12th Jul 20173:19 pmRNSHolding(s) in Company
12th Jul 20173:19 pmRNSHolding(s) in Company
30th Jun 20173:09 pmRNSMonthly Update
30th Jun 20173:07 pmRNSNet Asset Value(s)
29th Jun 20173:51 pmRNSHolding(s) in Company
28th Jun 20173:43 pmRNSHolding(s) in Company
26th Jun 20174:01 pmRNSDirector/PDMR Shareholding
26th Jun 20174:01 pmRNSDirector/PDMR Shareholding
26th Jun 20177:00 amRNSCorporate Update
22nd Jun 20174:59 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:05 pmRNSDirector/PDMR Shareholding
16th Jun 20175:05 pmRNSDirector/PDMR Shareholding
16th Jun 20174:25 pmRNSDirector/PDMR Shareholding
16th Jun 20174:20 pmRNSDividend Declaration
15th Jun 20175:19 pmRNSDirector/PDMR Shareholding
15th Jun 20175:07 pmRNSResult of AGM
15th Jun 20177:00 amRNSCorporate Update
2nd Jun 20173:39 pmRNSPublication of a Supplementary Prospectus
26th May 20175:35 pmRNSMonthly Update
26th May 20175:28 pmRNSNet Asset Value(s)
23rd May 20175:34 pmRNSDirector/PDMR Shareholding
18th May 20174:13 pmRNSHolding(s) in Company
17th May 20172:29 pmRNSPortfolio Update
15th May 20172:18 pmRNSMonthly Update
12th May 20177:00 amRNSNet Asset Value(s)
2nd May 20174:38 pmRNSTotal Voting Rights
28th Apr 20174:15 pmRNSAnnual Financial Report
12th Apr 20177:00 amRNSPortfolio update - Argon Credit
7th Apr 20172:47 pmRNSDirector/PDMR Shareholding
7th Apr 20177:00 amRNSAdmission to the Official List
31st Mar 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.